Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B liposomes in persistent febrile neutropenia
NCT05108545Phase 3Unknown
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Dec 2021
- Primary completion
- Jul 2022
- Modality
- Lipid-based Nanoparticles, Small Molecules
01
Overview
A Phase 3 trial of liposomal amphotericin b in febrile neutropenia (FN), sponsored by CSPC ZhongQi Pharmaceutical Technology. Status: unknown.
02
Drugs
liposomal amphotericin b
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT05108545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05108545.